BALAXIUpdated 1 Sept 2026, 12:18

Balaxi Pharma Ltd

BALAXIUpdated 1 Sept 2026, 12:18

Market Cap

₹127Cr.

Current Price

₹22.9

High / Low

₹47.9/15.2

Stock P/E

34.2

ROE3.95%

ROCE5.93%

Book Value₹24.1

Face Value₹2.00

Dividend Yield0.00%

About

Balaxi Pharmaceuticals Ltd is an IPR-based pharmaceutical Company engaged in producing, stocking, selling, and supplying branded and generic medicines.[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	30.42	0.00	—	—	146.81	249.73	202.23	187.78	264.25	399.11	538.13	289.83
Inventory Days	—	—	—	—	—	9.23	0.12	0.00	6.62	5.43	0.00	0.00
Days Payable	—	—	—	—	—	81.27	95.96	—	76.73	80.38	—	—
Cash Conversion Cycle	30.42	0.00	—	—	146.81	177.69	106.38	187.78	194.14	324.16	538.13	289.83
Working Capital Days	-669.17	-1,387.00	—	—	82.12	186.70	94.62	105.47	156.31	253.73	282.17	43.07
ROCE %	7.66%	-1.83%	-4.59%	-39.79%	96.25%	58.36%	55.40%	37.15%	27.93%	6.05%	5.06%	5.93%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 12:18

BALAXI PHARMA LTD (BALAXI) financials — quarterly results, P&L, cash flow, balance sheet, shareholding